Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.600
+0.080 (3.17%)
Nov 7, 2024, 4:00 PM EST - Market closed
Exagen Market Cap
Exagen has a market cap or net worth of $45.20 million as of November 7, 2024. Its market cap has increased by 68.64% in one year.
Market Cap
45.20M
Enterprise Value
44.82M
1-Year Change
68.64%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since September 19, 2019, Exagen's market cap has decreased from $63.11M to $45.20M, a decrease of -28.37%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2024 | 45.20M | 33.26% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | 319.05M | 405.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicarious Surgical | 46.03M |
| CollPlant Biotechnologies | 45.25M |
| SHL Telemedicine | 44.92M |
| Intensity Therapeutics | 44.64M |
| Immix Biopharma | 43.92M |
| Eyenovia | 43.21M |
| Achilles Therapeutics | 42.94M |
| Apyx Medical | 41.92M |